UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Propensity Score Matching: The ‘Devil is in the Details’ Where More May Be Hidden than You Know

The American journal of medicine, 2020-02, Vol.133 (2), p.178-181

Reiffel, James A.

2020

Volltextzugriff (PDF)

The Association of Bradycardic Event Risk With Antiarrhythmic Drugs for Atrial Fibrillation

Journal of the American College of Cardiology, 2024-09, Vol.84 (11), p.e79-e79

Reiffel, James A.

2024

Volltextzugriff (PDF)

Atrial Fibrillation: Why Are We Hiding Reality?

Circulation (New York, N.Y.), 2024-03, Vol.149 (13), p.979-980

Reiffel, James A

2024

Volltextzugriff (PDF)

Cowboys Will Always Be Cowboys—But Not Everyone Should Join the Rodeo

The American journal of cardiology, 2024-06, Vol.221, p.50-51

Reiffel, James A.

2024

Volltextzugriff (PDF)

Comparative effectiveness of monitoring duration for detection of potential or suspected arrhythmias

The American heart journal, 2024-08, Vol.274, p.113-114

Reiffel, James A.

2024

Volltextzugriff (PDF)

Cardioversion: The Breadth of Efficacy

The American journal of cardiology, 2023-09, Vol.203, p.503-504

Reiffel, James A.

2023

Volltextzugriff (PDF)

Time in the Therapeutic Range for Patients Taking Warfarin in Clinical Trials: Useful, but Also Misleading, Misused, and Overinterpreted

Circulation (New York, N.Y.), 2017-04, Vol.135 (16), p.1475-1477

Reiffel, James A

2017

Volltextzugriff (PDF)

Thank You, Dr Alpert

The American journal of medicine, 2023-06, Vol.136 (6), p.e127-e128

Reiffel, James A.

2023

Volltextzugriff (PDF)

Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome

Journal of the American College of Cardiology, 2022-09, Vol.80 (10), p.e75-e75

Reiffel, James A.

2022

Volltextzugriff (PDF)

Atrial Fibrillation: Is Rhythm Control Required, and If So, How, and What Is the Internist's Role?

The American journal of medicine, 2022-08, Vol.135 (8), p.939-944

Reiffel, James A.

2022

Volltextzugriff (PDF)

The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease – Fact or fallacy

The American heart journal, 2022-06, Vol.248, p.163-164

Reiffel, James A.

2022

Volltextzugriff (PDF)

Guidelines Are Meant to Guide, But They Are Not Absolute

The American journal of medicine, 2022-06, Vol.135 (6), p.e132-e132

Reiffel, James A.

2022

Volltextzugriff (PDF)

When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease

European heart journal, 2021-09, Vol.42 (35), p.3555-3557

Reiffel, James A

2021

Volltextzugriff (PDF)

Clinicians May Disagree About the Usefulness of the Physical Exam, but Those Who Refute It Are Wrong

The American journal of medicine, 2021-09, Vol.134 (9), p.e496-e496

Reiffel, James A.

2021

Volltextzugriff (PDF)

Letter by Reiffel Regarding Article, "Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative"

Circulation (New York, N.Y.), 2021-08, Vol.144 (8), p.e160-e160

Reiffel, James A

2021

Volltextzugriff (PDF)

Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?

Journal of the American College of Cardiology, 2020-11, Vol.76 (18), p.2179-2179

Reiffel, James A

2020

Volltextzugriff (PDF)

CHA2DS2-VASc is no longer enough

Europace (London, England), 2022-07, Vol.24 (7), p.1195-1195

Reiffel, James A

2022

Volltextzugriff (PDF)

Atrial Fibrillation and Stroke: Epidemiology

The American journal of medicine, 2014-04, Vol.127 (4), p.e15-e16

Reiffel, James A., MD

2014

Volltextzugriff (PDF)

The Interaction Among Atrial Thromboembolism, Atrial Fibrillation, and Atrial Cardiomyopathy

The American journal of cardiology, 2019-10, Vol.124 (8), p.1317-1317

Reiffel, James A.

2019

Volltextzugriff (PDF)

QT Interval Abnormalities with Pulmonary Emboli

The American journal of medicine, 2020-03, Vol.133 (3), p.e113-e113

Reiffel, James A

2020

Volltextzugriff (PDF)

“Pill in the Pocket” Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation

The American journal of cardiology, 2021-02, Vol.140, p.55-61

2021

Volltextzugriff (PDF)

Mass Screening for Atrial Fibrillation: The Hype, The Methods, and The Application

The American journal of medicine, 2019-06, Vol.132 (6), p.668-670

Reiffel, James A.

2019

Volltextzugriff (PDF)

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation

Annals of internal medicine, 2019-06, Vol.170 (11), p.818

Reiffel, James A

2019

Volltextzugriff (PDF)

Reader's Comments: Beyond Atrial Fibrillation Patterns as Contributors to Risk of Thromboembolism

The American journal of cardiology, 2019-07, Vol.124 (1), p.166-166

Reiffel, James A.

2019

Volltextzugriff (PDF)

When an Omission Alters the Message, Missing Facts Must be Added

The American journal of medicine, 2019-09, Vol.132 (9), p.e722-e722

Reiffel, James A.

2019

Volltextzugriff (PDF)

1 – 25 von 411

Menü

Weitere Dienste

Einstellungen

Propensity Score Matching: The ‘Devil is in the Details’ Where More May Be Hidden than You Know

The Association of Bradycardic Event Risk With Antiarrhythmic Drugs for Atrial Fibrillation

Atrial Fibrillation: Why Are We Hiding Reality?

Cowboys Will Always Be Cowboys—But Not Everyone Should Join the Rodeo

Comparative effectiveness of monitoring duration for detection of potential or suspected arrhythmias

Cardioversion: The Breadth of Efficacy

Time in the Therapeutic Range for Patients Taking Warfarin in Clinical Trials: Useful, but Also Misleading, Misused, and Overinterpreted

Thank You, Dr Alpert

Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome

Atrial Fibrillation: Is Rhythm Control Required, and If So, How, and What Is the Internist's Role?

The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease – Fact or fallacy

Guidelines Are Meant to Guide, But They Are Not Absolute

When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease

Clinicians May Disagree About the Usefulness of the Physical Exam, but Those Who Refute It Are Wrong

Letter by Reiffel Regarding Article, "Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative"

Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?

CHA2DS2-VASc is no longer enough

Atrial Fibrillation and Stroke: Epidemiology

The Interaction Among Atrial Thromboembolism, Atrial Fibrillation, and Atrial Cardiomyopathy

QT Interval Abnormalities with Pulmonary Emboli

“Pill in the Pocket” Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation

Mass Screening for Atrial Fibrillation: The Hype, The Methods, and The Application

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation

Reader's Comments: Beyond Atrial Fibrillation Patterns as Contributors to Risk of Thromboembolism

When an Omission Alters the Message, Missing Facts Must be Added

Suchergebnisse filtern